Can talking therapy ease the emotional toll of incurable cancer?

NCT ID NCT07124546

Recruiting now Symptom relief Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether Acceptance and Commitment Therapy (ACT), delivered through telehealth group sessions, can help reduce cancer-related distress in patients with incurable hepatobiliary or breast cancer. Participants will learn to cope with difficult thoughts and emotions while focusing on what matters most in life. The study aims to see if this approach is satisfying and feasible for patients, potentially offering a new way to improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Acceptance and Commitment Therapy (ACT) delivered via telehealth group sessions
What this could lead to: If effective, this therapy could offer a practical way to reduce emotional distress and improve quality of life for people facing incurable cancers.
What could go wrong: This is an early-stage study with a small number of participants, so results may not apply broadly. The therapy may not reduce distress for everyone, and participation requires internet access and English proficiency.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer hepatobiliary neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT HEPATOBILIARY NEOPLASM

Contacts and locations

Locations

Mayo Clinic in Rochester
RECRUITING

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.